Ultragenyx Pharmaceutical Inc.


Market Cap$3.58B

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Ultragenyx Pharmaceutical Inc.Ultragenyx Pharmaceutical Inc.-5.80%-437%7.6-

Target Price by Analysts

187.8% upsideUltragenyx Pharmaceutical Target Price DetailsTarget Price

Current Fair Value

45.4% upside

Undervalued by 45.4% based on the discounted cash flow analysis.

Share Statistics

Market cap$3.58 Billion
Enterprise Value$3.17 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$-7.96
Outstanding Shares83,133,341
Avg 30 Day Volume777,865


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-5.84
Price to Sales7.6
Price to Book Ratio38.02
Enterprise Value to Revenue7.17
Enterprise Value to EBIT-5.47
Enterprise Value to Net Income-6
Total Debt to Enterprise0
Debt to Equity0

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Ultragenyx Pharmaceutical Inc.

CEO: Emil Kakkis